Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Transcription factor ETV1 is essential for rapid conduction in the heart.

The Journal of clinical investigation | 2016

Rapid impulse propagation in the heart is a defining property of pectinated atrial myocardium (PAM) and the ventricular conduction system (VCS) and is essential for maintaining normal cardiac rhythm and optimal cardiac output. Conduction defects in these tissues produce a disproportionate burden of arrhythmic disease and are major predictors of mortality in heart failure patients. Despite the clinical importance, little is known about the gene regulatory network that dictates the fast conduction phenotype. Here, we have used signal transduction and transcriptional profiling screens to identify a genetic pathway that converges on the NRG1-responsive transcription factor ETV1 as a critical regulator of fast conduction physiology for PAM and VCS cardiomyocytes. Etv1 was highly expressed in murine PAM and VCS cardiomyocytes, where it regulates expression of Nkx2-5, Gja5, and Scn5a, key cardiac genes required for rapid conduction. Mice deficient in Etv1 exhibited marked cardiac conduction defects coupled with developmental abnormalities of the VCS. Loss of Etv1 resulted in a complete disruption of the normal sodium current heterogeneity that exists between atrial, VCS, and ventricular myocytes. Lastly, a phenome-wide association study identified a link between ETV1 and bundle branch block and heart block in humans. Together, these results identify ETV1 as a critical factor in determining fast conduction physiology in the heart.

Pubmed ID: 27775552 RIS Download

Research resources used in this publication

None found

Antibodies used in this publication

None found

Associated grants

  • Agency: NCATS NIH HHS, United States
    Id: UL1 TR001445
  • Agency: NCATS NIH HHS, United States
    Id: UL1 TR000445
  • Agency: NCI NIH HHS, United States
    Id: P30 CA016087
  • Agency: NLM NIH HHS, United States
    Id: R01 LM010685
  • Agency: NHGRI NIH HHS, United States
    Id: U01 HG004603
  • Agency: NIGMS NIH HHS, United States
    Id: R01 GM057691
  • Agency: NHGRI NIH HHS, United States
    Id: U01 HG008672
  • Agency: NIGMS NIH HHS, United States
    Id: T32 GM066704
  • Agency: NHLBI NIH HHS, United States
    Id: F31 HL132438
  • Agency: NHLBI NIH HHS, United States
    Id: R01 HL105983
  • Agency: NIGMS NIH HHS, United States
    Id: P50 GM115305
  • Agency: NHGRI NIH HHS, United States
    Id: U01 HG006378
  • Agency: NCRR NIH HHS, United States
    Id: UL1 RR024975
  • Agency: NCATS NIH HHS, United States
    Id: UL1 TR000038

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


New York University School of Medicine Langone Health Microscopy Laboratory Core Facility (tool)

RRID:SCR_017934

Core offers comprehensive light and electron microscopy technologies. Our scientists use light microscopes and electron microscopes at resolutions ranging from centimeters to angstroms, providing clear and detailed images.We assist at every stage of your experiment, offering research-design consultation and instrument training, as well as guidance in study execution, analysis, and presentation for publication.

View all literature mentions